Search

everythinglearnresearchcommunity

for

Search:↓

Tofacitinib helped most patients with alopecia areata regrow hair and changes in immune cells were linked to the treatment's effectiveness.

JAK inhibitors are safe and effective for treating moderate-to-severe alopecia areata.

Blocking certain immune signals can reduce skin damage from radiation therapy.

Tofacitinib may effectively treat skin symptoms in difficult cases of dermatomyositis.

Some drugs, especially biologics, can cause skin reactions that look like other skin diseases, and stopping the drug usually helps clear up these reactions.

IL-18 signaling helps mature Tregs move into the thymus.

Combining MMP-9 and JAK inhibitors can effectively prevent skin depigmentation in vitiligo.

TNFα and interleukin-1 blockers reduce skin inflammation from EGFR antibody therapy.

More effective treatments are needed for alopecia areata, hidradenitis suppurativa, and vitiligo.

Tofacitinib regrew hair in a man with total hair loss but raised cytokine levels, needing more research on possible side effects.

MTX and GC combinations are the most effective for early rheumatoid arthritis.

JAK inhibitors effectively treat inflammatory skin diseases by targeting specific cytokine signals.

Pharmaceutical care in transplantation faces challenges but has promising future opportunities for better outcomes.

Flammulina velutipes polysaccharide helps the immune system fight tumors by activating certain pathways.

People with alopecia areata have fewer regulatory T-cells than those with other skin conditions.

Eculizumab helps reduce blood transfusions and stabilize hemoglobin but increases infection risk and is expensive.

Alopecia universalis from alemtuzumab in multiple sclerosis can be reversed with specific treatments.

TNFα and interleukin-1 blockers reduce skin inflammation from EGFR antibody therapy.

Some elderly men had healing problems after using imiquimod and diclofenac for skin conditions on their scalps.

Increasing regulatory T cells may help treat alopecia areata by reducing autoimmunity and promoting hair growth.

IMG-007 helps regrow hair and reduce scalp inflammation in severe alopecia areata.

Anti-PD-L1 immunotherapy can cause hair loss and unexpected hair color change, but treatment can restore hair growth and color.

Two drugs, tofacitinib and ruxolitinib, may help regrow hair by activating hair follicles.

Upadacitinib effectively improved severe atopic dermatitis and alopecia universalis in a 29-year-old man.

Immune checkpoint inhibitors can cause scalp inflammation and hair follicle issues.

IL-17 plays a key role in severe hair loss in chronic alopecia areata.

Some medications might reverse gray hair, especially those that reduce inflammation or stimulate pigment production, and vitamin B might help.

Regulatory T cells adapt to different environments to control inflammation and support tissue repair.

Tissue-resident memory T cells can protect against infections and cancer but may also contribute to autoimmune diseases.